Who we are
AxTalis is a team of dedicated professionals to support or integrate with your Market Acces or Medical Affairs team. Having collaborated with biotech companies, start-ups & universities, we bring industry experience in Commercial, Marketing, Access, Medical Affairs and Research.
As the complexity of the environment increases, Medical Affairs and Market Access functions are working closer together than ever to face the challenges of obtaining and sustaining the right price and conditions for therapeutics. Companies often lack the manpower or are unable to prioritise this process, even though it lays the basis for commercialisation for years to come.
AxTalis was created to support companies by offering a dedicated cross-functional team as-a-service. This team combines the clinical and economic viewpoints and works closely with our clients for preparation, implementation and follow-up of the access and launch strategy.
Managing Partner - Market Access
Sven is a seasoned expert with of 20 years of experience in both hands-on and managerial roles in Commercial and Market Access. He leverages an extensive network of stakeholders both in the clinical arena and at the level of government and sick funds. He is intimately familiar with the influencers and decision makers when it comes to access to innovation.
Managing Partner - Medical Affairs
Frank is a pharmacist and experienced pharma executive with a focus on strategy and patient value. He has developed and implemented numerous medico-marketing projects, both for major pharmaceutical companies and for start-ups. He leverages the experience from roles as MSL manager and Medical Director to gather and build insights. The analytical skills from his Business Intelligence and Competitive Intelligence years support the development of the value story, launch strategy and projects.
Sr. Medical Manager
Katelijne is an MD, PhD with a vast research and pharma industry experience. From hands-on medical management to leading large teams and country affiliates for major pharma, she is intimately familiar with the inner workings and the needs of our clients in a wide range of therapeutic areas and technologies.
Market Access - Data analytics
A pharmacist by education with specialty in drug development, Lena joined AxTalis early on. Her insight in complex data sets and skills to manipulate them as well as her understanding of the processes and social skills for stakeholder interactions, make her a valued partner inside of AxTalis and for our clients.
As the “New” launch ecosystem is characterised by increased complexity, it requires solid fundamentals for success. We believe that Market Access is shifting from a push towards a pull-through approach. Within this shift, we are convinced that Medical Affairs plays a critical role in managing this complexity.
Value proposition development
Co-development with stakeholders
Anticipating the day after tomorrow
We trust in science as a driver for medical innovations. From the discovery to the generation of evidence, science is what brings medical innovations to patients
We believe that bringing medical innovations to patients is not only a collaborative effort within internal teams, it is also about openly engaging around the needs of external stakeholders.
We consider creating an impact for patients the most important task at hand. Our goal is to demonstrate the value of the right medical innovation for the right patient.